These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

221 related articles for article (PubMed ID: 12084397)

  • 21. Rapid, estrogen receptor-mediated signaling: why is the endothelium so special?
    Kim KH; Bender JR
    Sci STKE; 2005 Jun; 2005(288):pe28. PubMed ID: 15956360
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Regulation of endothelial nitric oxide synthase and high-density lipoprotein quality by estradiol in cardiovascular pathology.
    Kypreos KE; Zafirovic S; Petropoulou PI; Bjelogrlic P; Resanovic I; Traish A; Isenovic ER
    J Cardiovasc Pharmacol Ther; 2014 May; 19(3):256-68. PubMed ID: 24414281
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Striatin assembles a membrane signaling complex necessary for rapid, nongenomic activation of endothelial NO synthase by estrogen receptor alpha.
    Lu Q; Pallas DC; Surks HK; Baur WE; Mendelsohn ME; Karas RH
    Proc Natl Acad Sci U S A; 2004 Dec; 101(49):17126-31. PubMed ID: 15569929
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Hormone replacement therapy and cardiovascular disease: what went wrong and where do we go from here?
    Dubey RK; Imthurn B; Zacharia LC; Jackson EK
    Hypertension; 2004 Dec; 44(6):789-95. PubMed ID: 15477384
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Estrogen receptor activation of phosphoinositide-3 kinase, akt, and nitric oxide signaling in cerebral blood vessels: rapid and long-term effects.
    Stirone C; Boroujerdi A; Duckles SP; Krause DN
    Mol Pharmacol; 2005 Jan; 67(1):105-13. PubMed ID: 15496504
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Estrogens and Coronary Artery Disease: New Clinical Perspectives.
    Meyer MR; Barton M
    Adv Pharmacol; 2016; 77():307-60. PubMed ID: 27451102
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Cardiovascular protection by estrogen: a hemodynamic mechanism?
    Rozenberg S; Liebens I; Vandromme J; Hotimsky A; Van Rijsselberge M
    Int J Fertil Menopausal Stud; 1994; 39 Suppl 1():36-42. PubMed ID: 8199639
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Cardiovascular physiopathology of ovarian hormones].
    de Ziegler D
    Praxis (Bern 1994); 1997 Jan; 86(5):138-44. PubMed ID: 9064731
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The nongenomic protective effects of estrogen on the male cardiovascular system: clinical and therapeutic implications in aging men.
    Cho JJ; Cadet P; Salamon E; Mantione K; Stefano GB
    Med Sci Monit; 2003 Mar; 9(3):RA63-8. PubMed ID: 12640355
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Mechanisms of estrogen effects on the endothelium: an overview.
    Chakrabarti S; Morton JS; Davidge ST
    Can J Cardiol; 2014 Jul; 30(7):705-12. PubMed ID: 24252499
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Effects of estrogen on the vascular system.
    Tostes RC; Nigro D; Fortes ZB; Carvalho MH
    Braz J Med Biol Res; 2003 Sep; 36(9):1143-58. PubMed ID: 12937779
    [TBL] [Abstract][Full Text] [Related]  

  • 32. 27-Hydroxycholesterol is an endogenous SERM that inhibits the cardiovascular effects of estrogen.
    Umetani M; Domoto H; Gormley AK; Yuhanna IS; Cummins CL; Javitt NB; Korach KS; Shaul PW; Mangelsdorf DJ
    Nat Med; 2007 Oct; 13(10):1185-92. PubMed ID: 17873880
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Combined lack of estrogen receptors alpha and beta affects vascular iNOS protein expression.
    Liang M; Ekblad E; Lydrup ML; Nilsson BO
    Cell Tissue Res; 2003 Jul; 313(1):63-70. PubMed ID: 12827494
    [TBL] [Abstract][Full Text] [Related]  

  • 34. HDL-associated estradiol stimulates endothelial NO synthase and vasodilation in an SR-BI-dependent manner.
    Gong M; Wilson M; Kelly T; Su W; Dressman J; Kincer J; Matveev SV; Guo L; Guerin T; Li XA; Zhu W; Uittenbogaard A; Smart EJ
    J Clin Invest; 2003 May; 111(10):1579-87. PubMed ID: 12750408
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Complete and selective estrogenic effects on lipids and cardiovascular disease.
    Lamon-Fava S
    Curr Atheroscler Rep; 2000 Jan; 2(1):72-5. PubMed ID: 11122727
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Truncated estrogen receptor alpha 46-kDa isoform in human endothelial cells: relationship to acute activation of nitric oxide synthase.
    Figtree GA; McDonald D; Watkins H; Channon KM
    Circulation; 2003 Jan; 107(1):120-6. PubMed ID: 12515753
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Comparative cardiovascular effects of different progestins in menopause.
    Rosano GM; Fini M
    Int J Fertil Womens Med; 2001; 46(5):248-56. PubMed ID: 11720197
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Estrogens and the vascular endothelium.
    Cid MC; Schnaper HW; Kleinman HK
    Ann N Y Acad Sci; 2002 Jun; 966():143-57. PubMed ID: 12114268
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Structure-function relationship of estrogen receptors in cardiovascular pathophysiological models.
    Arnal JF; Valéra MC; Payrastre B; Lenfant F; Gourdy P
    Thromb Res; 2012 Oct; 130 Suppl 1():S7-11. PubMed ID: 23026669
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Vascular cell signaling by membrane estrogen receptors.
    Hisamoto K; Bender JR
    Steroids; 2005; 70(5-7):382-7. PubMed ID: 15862821
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.